Scholarlink

Background <p>Short-chain fatty acids produced by microorganisms living in the gastrointestinal tract are known to have numerous beneficial effects. Because certain probiotic strains may influence short-chain fatty acid production, probiotic supplementation has been proposed as a potential strategy to modify faecal short-chain fatty acid concentrations. Our aim was to investigate whether probiotics modify faecal short-chain fatty acid levels in healthy populations via systematic review and meta-analysis.</p> Methods <p>We performed a systematic search of the MEDLINE, Embase, and Cochrane databases on 12/04/2024. We analysed exclusively randomized controlled trials meeting all the following criteria: population: healthy people; intervention: probiotic supplementation; control: no probiotic supplementation; outcome: faecal short-chain fatty acid concentrations. A total of 9217 articles were reviewed, 21 of which met the preset inclusion criteria. Twelve articles, including 541 subjects, were eligible for meta-analysis of changes in faecal short-chain fatty acid concentrations. The standardized mean difference (SMD, Hedges’ g) was chosen as the effect indicator due to the different measurement techniques used. A random-effects model was used to estimate SMD with 95% confidence interval (CI) due to the expected heterogeneity.</p> Results <p>No statistically significant differences were detected in the faecal butyrate (SMD = 0.07, 95%CI:[(-)0.16 – 0.30]), acetate (SMD = 0.06, 95%CI:[(-)0.14 – 0.27]), and propionate (SMD = 0.09, 95%CI:[(-)0.07 – 0.25]) levels between individuals taking and not taking probiotics.</p> Conclusions <p>Our results suggest that probiotic intake has a minor effect on faecal short-chain fatty acid concentrations, but this effect is not statistically detectable in healthy individuals. Thus, there is insufficient evidence of statistically significant effect of probiotic supplementation on stool short-chain fatty acid concentrations in healthy individuals.</p> Trial registration <p>Research protocol was registered in PROSPERO (CRD42022286137).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of probiotic supplementation on faecal short-chain fatty acid concentrations in healthy individuals: a systematic review and meta-analysis of randomized controlled trials

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月13日

查看全文
  • Kincső Csepke Földvári-Nagy,
  • Yasmin Zubeida Al-Gharati,
  • Dániel Sándor Veres,
  • Tamás Schnabel,
  • Katalin Lenti,
  • Anna Júlia Éliás,
  • László Földvári-Nagy

摘要

Background

Short-chain fatty acids produced by microorganisms living in the gastrointestinal tract are known to have numerous beneficial effects. Because certain probiotic strains may influence short-chain fatty acid production, probiotic supplementation has been proposed as a potential strategy to modify faecal short-chain fatty acid concentrations. Our aim was to investigate whether probiotics modify faecal short-chain fatty acid levels in healthy populations via systematic review and meta-analysis.

Methods

We performed a systematic search of the MEDLINE, Embase, and Cochrane databases on 12/04/2024. We analysed exclusively randomized controlled trials meeting all the following criteria: population: healthy people; intervention: probiotic supplementation; control: no probiotic supplementation; outcome: faecal short-chain fatty acid concentrations. A total of 9217 articles were reviewed, 21 of which met the preset inclusion criteria. Twelve articles, including 541 subjects, were eligible for meta-analysis of changes in faecal short-chain fatty acid concentrations. The standardized mean difference (SMD, Hedges’ g) was chosen as the effect indicator due to the different measurement techniques used. A random-effects model was used to estimate SMD with 95% confidence interval (CI) due to the expected heterogeneity.

Results

No statistically significant differences were detected in the faecal butyrate (SMD = 0.07, 95%CI:[(-)0.16 – 0.30]), acetate (SMD = 0.06, 95%CI:[(-)0.14 – 0.27]), and propionate (SMD = 0.09, 95%CI:[(-)0.07 – 0.25]) levels between individuals taking and not taking probiotics.

Conclusions

Our results suggest that probiotic intake has a minor effect on faecal short-chain fatty acid concentrations, but this effect is not statistically detectable in healthy individuals. Thus, there is insufficient evidence of statistically significant effect of probiotic supplementation on stool short-chain fatty acid concentrations in healthy individuals.

Trial registration

Research protocol was registered in PROSPERO (CRD42022286137).